Erstellt von conna
Amgen Inc. diskutieren
Amgen Inc.
WKN: 867900 / Symbol: AMGN / Name: Amgen / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
285,45 €
1,49 %
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Oppenheimer Holdings Inc. from $290.00 to $300.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $320.00 price target on the stock, up previously from $260.00.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $320.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $326.00 price target on the stock, up previously from $286.00.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to a "buy" rating. They now have a $320.00 price target on the stock, up previously from $264.00.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $350.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $313.00 to $350.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $303.00 to $329.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $329.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $320.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at TD Cowen from $370.00 to $360.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at BMO Capital Markets from $336.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Royal Bank of Canada from $332.00 to $328.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $328.00 to $332.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Argus from $300.00 to $340.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $332.00 to $362.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $380.00 price target on the stock, up previously from $375.00.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $380.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Dbs Bank to a "strong-buy" rating.
Ratings data for AMGN provided by MarketBeat
Neueste Beiträge
Telsey_Advisory_Grou in Bath & Body Works Inc. diskutieren